• Fujifilm says COVID-19 drug research may drag on into July
    TOKYO, June 7 (Reuters) - Fujifilm Holdings Corp's <4901.T> research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.   "There is a possibility that clinical trials will continue in July," a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.
  • Nicotine aids spread of lung cancer to brain: Study
    New York, June 6 (IANS) Researchers have found that that nicotine, a non-carcinogenic chemical found in tobacco, actually promotes the spread of lung cancer cells into the brain where they can form deadly metastatic tumours.   Smokers are far more likely to develop lung cancer than non-smokers, the study said.   "Based on our findings, we don't think that nicotine replacement products are the safest way for people with lung cancer to stop smoking," s
  • High blood pressure patients more likely to die from Covid-19: Study
    Beijing, June 5 (IANS) Patients with raised blood pressure have a two-fold increased risk of dying from the coronavirus (Covid-19) compared to patients without high blood pressure, warn researchers.   In addition, the study, published in the European Heart Journal, found that patients with high blood pressure who were not taking medication to control the condition were at even greater risk of dying from Covid-19.   "It is important that patients with high blo
  • Air pollution can pose serious threat to brain health: Study
    New York, June 5 (IANS) Although the impact of inhaling polluted air on the lungs is well known, now the researchers have revealed that it can pose a serious threat to brain health as well.   The study, published in the journal Chemical & Engineering News, details how researchers are connecting air pollution to dementia, autism and other neurological diseases.   Air pollution has become a fact of modern life, with a majority of the global population facing chr
  • Covid-19 lockdowns worsen childhood obesity globally: Study
    New York, June 4 (IANS) Lockdowns implemented across the world due to the COVID-19 pandemic have negatively impacted diet, sleep and physical activity among children with obesity, warn researchers.   "The tragic Covid-19 pandemic has collateral effects extending beyond direct viral infection," said study co-author Myles Faith from the University at Buffalo in the US.   "Children and teens struggling with obesity are placed in an unfortunate position
  • 'Covid-19 vac not possible soon'
    BY SUMIT SAXENA New Delhi, June 4 (IANS) It is not possible to develop a vaccine for Covid-19 soon, as the RNA virus changes very quickly and this makes it difficult to create a good vaccine, says Claudio Colosio Unimi Professor, Department of Health Sciences University of Milan, Italy.   Claudio as the Director, Occupational Health Unit of the Hospitals Saints Paolo and Carlo of Milano, has been extensively handling the Covid-19 pandemic. When queried about a vaccine sti
  • Antiepileptic drugs linked to high death risk in Alzheimer's patients
    London, June 4 (IANS) Researchers have claimed that the use of antiepileptic drugs is associated with a higher risk of death among people with Alzheimer's disease.   Anti-epileptic drugs (AEDs) are the main type of treatment for most people with epilepsy that aims to stop seizures.   The study, published in the journal Neurology, showed that the mortality risk increased considerably during the first three months of treatment with antiepileptic drugs.  
  • Eating whole grains helps cut diabetes risk
    New York, June 2 (IANS) Eating higher intake of high-quality carbohydrates, especially from whole grains, are associated with a lower risk for type 2 diabetes, say researchers.   "High intake of carbohydrates has been suggested to be associated with a higher risk of type 2 diabetes," said study lead author Kim Braun from Harvard University in the US.   For the findings, the research team looked at whether this effect is different for high-quality carbohy
  • Covid-19 could be seasonal illness with higher risk in winter: Study
    Image for representational purpose only   Sydney, June 2 (IANS) Covid-19 could be a seasonal illness with a higher risk in winter as researchers have found a one per cent decrease in humidity could increase the number of Covid-19 cases by six per cent.   The study, published in the journal Transboundary and Emerging Diseases, has found an association between lower humidity and an increase in locally acquired positive cases.   "Covid-19 is likely to
  • Choline helps lower effects of Covid-19 on newborns: Study
    New York, June 2 (IANS) Pregnant women who take extra choline supplements may be able to mitigate the negative impact viral respiratory infections, including Covid-19, may have on their babies, say researchers.   Choline is a vitamin B nutrient found in various foods and dietary supplements and is critical to fetal brain development.   "The Centers for Disease Control and Prevention (CDC) predicts that Covid-19 will impact fetal brain development like other c
  • Roche gets green signal for COVID antibody test
    New Delhi, June 1 (IANS) Roche Diagnostics India on Monday said it welcomed Indian Council of Medical Research's communication regarding its COVID-19 antibody test for seroprevalence studies in India.   Dr Shravan Subramanyam, Managing Director, Roche Diagnostics India said, "Roche Diagnostics India welcomes ICMR's communication that cites making available Roche COVID-19 antibody test for seroprevalence studies in India."   According to Subramany
  • Russia to roll out its first approved Covid-19 drug next week
    Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview   Moscow, June 1 (Reuters): Russia will start giving its first drug approved to treat Covid-19 to patients next week, its state financial backer told Reuters, a move it hopes will ease strains on the health system and speed a return to normal economic life.   R
  • Dairy intake may not prevent age-related bone loss in women: Study
    New York, June 1 (IANS) Researchers have found that despite containing essential nutrients, dairy products do not benefit lumbar spine or femoral neck bone density, nor do they protect against fracture risk in women.   The study, based on data from the Study of Women's Health Across the Nation (SWAN) shows that during the menopause transition, when bone loss is accelerated, they offer little benefit in preventing bone mineral density loss or fractures.   Accor
  • COVID-19 patients who undergo surgery at high death risk: Lancet
    London, May 31 (IANS) Researchers, including one of Indian-origin, have found that patients undergoing surgery after contracting COVID-19 are at greatly increased risk of postoperative death, according to a new global study published in The Lancet journal.   Published in 'The Lancet' journal, the global study found that amongst SARS-CoV-2 infected patients who underwent surgery, mortality rates approach those of the sickest patients admitted to intensive care after c
  • New method to help epidemiologists map COVID-19 spread
    New York, May 31 (IANS) Researchers have developed a method they believe will help epidemiologists predict more efficiently the spread of the COVID-19 pandemic.   The study, published in the journal Physica D: Nonlinear Phenomena, outlines a solution to the 'SIR' epidemic model, which is commonly used to predict how many people are susceptible to, infected by, and recovered from viral epidemics.   The method has been created by researchers from the Rochest
  • 'Covid-19 vac likely in 2020, but production only by 2021-end'
    New Delhi, May 30 (IANS) Sweden's chief epidemiologist Dr Anders Tegnell said Covid-19 vaccine may be developed in 2020, but its production will only start by the end of 2021.   In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of Covid-19 Sweden's lockdown-lite, said: "To reach full herd immunity to stop the disease and may be get rid of the disease in the long term, by certain you need a vaccine.   "
  • Covid-19 vaccine could be ready by October, claims Pfizer CEO
    New York, May 30 (IANS) Global pharmaceutical major Pfizer believes that a vaccine to prevent Covid-19 could be ready by the end of October, the company's CEO Albert Bourla said.   Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech.   Bourla made the comments while participating at a virtual event organised by the International Federation of Pharmaceu
  • Timely heart surgery saves woman's life amid corona lockdown
    New Delhi, May 29 (IANS) Even as non-COVID patients were facing problems in getting treatment amid the novel coronavirus outbreak, a very high-risk open-heart surgery at a hospital in Delhi helped save a 31-year-old woman's life during the ongoing nationwide lockdown.   Kirti of Rohini was suffering from chronic cardiac ailments for the past four years, though her condition deteriorated severely in the last week of April amid the lockdown. She required an urgent open-hea
  • Early exposure to anaesthetics may trigger alcohol use disorder
    New York, May 28 (IANS) Early exposure to anaesthetics in life may make adolescents more susceptible to developing alcohol use disorder (AUD), warn researchers.   Anaesthetics are commonly used drugs in the healthcare field and are often administered to children to induce unconsciousness and immobility during surgeries.   For the findings, published in the journal Alcoholism: Clinical & Experimental Research, the research team examined whether exposure to anes
  • Prevalence of 'silent' Covid-19 infections much higher than thought
    Sydney, May 28 (IANS) The prevalence of 'silent' symptomless COVID-19 infections may be much higher than thought and as countries progress out of lockdown, a high proportion of asymptomatic individuals may mean a much higher percentage has been infected with the coronavirus, according to a study of people isolated on a cruise ship during the pandemic.   Published in the journal Thorax, the study from Australian researchers revealed that more than eight out of 10 of p